pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Erythromycin
drug
save

erythromycin

Marketedupdated 3mo ago
by Fougera Pharmaceuticals Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 2
  • tagApproval2 co-mentions · 1 sources
  • tagSmall Molecule1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying erythromycin

  • phase1A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participantscompletedn=49
  • phase1A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Bloodcompletedn=20
  • phase2FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasmsactive not recruitingn=47
  • phase1A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)completedn=16
  • phase1Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteerscompletedn=24
  • phase1A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adultscompletedn=172

News(0)

no news has mentioned this drug yet

brand
Erythromycin
generic
erythromycin [INN]
indication
Acne Vulgaris
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 36m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?